• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于孕期电子健康干预对母体身体成分及随后围产期结局影响的随机试验

An eHealth Intervention in Pregnancy on Maternal Body Composition and Subsequent Perinatal Outcomes: A Randomized Trial.

作者信息

Kebbe Maryam, Falkenhain Kaja, Beyl Robbie, Altazan Abby D, Flanagan Emily W, Kracht Chelsea L, Cabre Hannah E, Woolf Emily K, Hsia Daniel S, Apolzan John W, Redman Leanne M

机构信息

Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Faculty of Kinesiology, University of New Brunswick, Fredericton, New Brunswick, Canada.

出版信息

Obesity (Silver Spring). 2025 Sep;33(9):1680-1693. doi: 10.1002/oby.24357. Epub 2025 Jul 24.

DOI:10.1002/oby.24357
PMID:40707419
Abstract

OBJECTIVE

To examine the effects of a pragmatic multicomponent eHealth intervention in pregnancy on body composition changes and subsequent associations with perinatal outcomes.

METHODS

Pregnant individuals (n = 351) enrolled in Louisiana's Women, Infants, and Children program were randomly assigned to a multicomponent eHealth Intervention or Usual Care. Fat percentage, fat mass, and fat-free mass were assessed using bioelectrical impedance at trimester-specific study visits. Mixed models evaluated within- and between-group differences in body composition from early to late pregnancy: overall, by BMI, and by gestational weight gain (GWG) guideline attainment. Effects of body composition changes on perinatal outcomes was evaluated.

RESULTS

Compared to Usual Care (n = 172), the Intervention Group (n = 179) had attenuated gains in fat mass, fat mass index, and fat percentage from early to late pregnancy overall, in individuals who had normal weight at enrollment, and in those who exceeded GWG guidelines (p < 0.05). No significant between-group differences in fat-free mass were observed. Fat mass change interacted with intervention effects on neonatal health outcomes (p = 0.01).

CONCLUSIONS

Lifestyle interventions during pregnancy may attenuate gestational fat mass gain, particularly among women with normal weight and those who exceed GWG guidelines, with potential implications for neonatal health outcomes.

TRIAL REGISTRATION

ClinicalTrials.gov identifier: NCT04028843.

摘要

目的

研究一种实用的多成分电子健康干预措施对孕期身体成分变化及其与围产期结局后续关联的影响。

方法

纳入路易斯安那州妇女、婴儿和儿童项目的孕妇(n = 351)被随机分配至多成分电子健康干预组或常规护理组。在特定孕期的研究访视中,使用生物电阻抗法评估脂肪百分比、脂肪量和去脂体重。混合模型评估从孕早期到孕晚期身体成分的组内和组间差异:总体情况、按体重指数(BMI)以及按孕期体重增加(GWG)指南达标情况进行评估。评估身体成分变化对围产期结局的影响。

结果

与常规护理组(n = 172)相比,干预组(n = 179)在总体上、入组时体重正常的个体以及超过GWG指南的个体中,从孕早期到孕晚期的脂肪量、脂肪量指数和脂肪百分比增加有所减缓(p < 0.05)。未观察到组间去脂体重有显著差异。脂肪量变化与干预对新生儿健康结局的影响存在交互作用(p = 0.01)。

结论

孕期的生活方式干预可能会减缓孕期脂肪量的增加,尤其是在体重正常的女性和超过GWG指南的女性中,这可能对新生儿健康结局产生潜在影响。

试验注册

ClinicalTrials.gov标识符:NCT04028843。

相似文献

1
An eHealth Intervention in Pregnancy on Maternal Body Composition and Subsequent Perinatal Outcomes: A Randomized Trial.一项关于孕期电子健康干预对母体身体成分及随后围产期结局影响的随机试验
Obesity (Silver Spring). 2025 Sep;33(9):1680-1693. doi: 10.1002/oby.24357. Epub 2025 Jul 24.
2
Metabolic Health and Heterogenous Outcomes of Prenatal Interventions: A Secondary Analysis of a Randomized Clinical Trial.产前干预的代谢健康与异质性结局:一项随机临床试验的二次分析
JAMA Netw Open. 2025 Aug 1;8(8):e2528264. doi: 10.1001/jamanetworkopen.2025.28264.
3
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.
4
Weight loss prior to pregnancy and subsequent gestational weight gain: Prepare, a randomized clinical trial.孕前体重减轻和随后的孕期体重增加:Prepare,一项随机临床试验。
Am J Obstet Gynecol. 2021 Jan;224(1):99.e1-99.e14. doi: 10.1016/j.ajog.2020.07.027. Epub 2020 Jul 18.
5
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
6
[A randomized controlled trial of weight management based on mobile health techno-logy among overweight or obese pregnant women].[一项基于移动健康技术对超重或肥胖孕妇进行体重管理的随机对照试验]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):465-472. doi: 10.19723/j.issn.1671-167X.2025.03.009.
7
Diet or exercise, or both, for preventing excessive weight gain in pregnancy.饮食或运动,或两者结合,用于预防孕期体重过度增加。
Cochrane Database Syst Rev. 2015 Jun 15;2015(6):CD007145. doi: 10.1002/14651858.CD007145.pub3.
8
Protocol for a randomised controlled trial of a weight maintenance intervention to promote fat loss in pregnant individuals with obesity.一项体重维持干预促进肥胖孕妇减脂的随机对照试验方案。
BMJ Open. 2025 Feb 25;15(2):e095804. doi: 10.1136/bmjopen-2024-095804.
9
Lifestyle interventions for the treatment of women with gestational diabetes.生活方式干预治疗妊娠期糖尿病女性
Cochrane Database Syst Rev. 2017 May 4;5(5):CD011970. doi: 10.1002/14651858.CD011970.pub2.
10
Insulin for the treatment of women with gestational diabetes.用于治疗妊娠期糖尿病女性的胰岛素。
Cochrane Database Syst Rev. 2017 Nov 5;11(11):CD012037. doi: 10.1002/14651858.CD012037.pub2.